Medprogresas - Company finances
|
EUR
|
2021
From: 2021-04-14
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 116,989 | 280,439 | 258,020 | 262,983 |
| Profit before tax | - | - | - | - | - |
| Net profit | -8,005 | -20,144 | 9,402 | 12,704 | 766 |
| Equity | -5,505 | -25,649 | 18,752 | 31,456 | 32,223 |
| Liabilities | 212,788 | 339,630 | 283,800 | 213,596 | 175,823 |
| Non-current assets | 97,538 | 258,146 | 232,676 | 185,016 | 131,606 |
| Current assets | 109,745 | 55,835 | 66,750 | 56,708 | 72,738 |
| Total assets | 207,283 | 313,981 | 299,426 | 241,724 | 204,344 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 49,939 | 37,634 | 38,571 |
| Social insurance contributions | - | - | 27,187 | 18,758 | 25,813 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +139.7% | -8.0% | +1.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.9% | -6.4% | 3.1% | 5.3% | 0.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 50.1% | 40.4% | 2.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -17.2% | 3.4% | 4.9% | 0.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 15.1 | 6.8 | 5.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 20,645 | 41,040 | 35,185 | 33,572 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medprogresas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-10-30 | 0.06 |
| 2025-07-16 | 2025-07-20 | 35.82 |
| 2025-05-16 | 2025-05-18 | 0.32 |
| 2022-11-17 | 2022-11-18 | 0.10 |
| 2022-10-31 | 2022-11-07 | 0.10 |
Medprogresas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-20 | 2026-05-20 | 22.75 |
| 2026-01-29 | 2026-02-21 | 0.75 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medprogresas, UAB (code 305734741) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €263.0K and net profit of €766, which resulted in a slim profit margin of 0.3%. Revenue increased by 1.9% year on year, although it remained 6.2% below the 2023 level. Over the last three years, revenue moved from €280.4K in 2023 to €258.0K in 2024 and then recovered slightly in 2025. Net profit followed a weaker path, rising from €9.4K in 2023 to €12.7K in 2024 before falling sharply in 2025. At the end of 2025, total assets stood at €204.3K, with equity of €32.2K and liabilities of €175.8K. The balance sheet indicates an equity ratio of 15.8% and debt-to-equity of 5.46, while asset turnover was 1.29x. Productivity was modest, with revenue per employee of €37.6K and profit per employee of €109.